Prescribing History Review
Prescribing history tooling consolidates medication records, dose trajectories, and fill patterns into a reviewable timeline, giving the prescriber context that fragmented chart review often obscures.
Custom Software
AI Pain Management Software Development
AI pain management software applies machine learning to prescribing history, patient-reported outcomes, and treatment records to support clinicians with risk review, response tracking, and documentation. It functions as decision support only: the prescriber makes every treatment, tapering, and medication decision, and no patient is denied care by software.
Pain management sits at the intersection of clinical need, regulatory scrutiny, and genuine risk, which makes software design in this field unusually consequential. Taction Software builds AI pain management tooling that surfaces context for the prescriber without producing scores that gate access to treatment. We have shipped FDA-registered pain applications, including Revive Ease and PainKare, so this domain is familiar ground.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Pain Management Software
AI pain management software refers to machine learning and workflow automation applied to pain care: prescribing history review, patient-reported outcome tracking, functional assessment trends, procedure documentation, and behavioral health coordination. Models organize longitudinal data and surface patterns for clinician review, including factors associated with elevated risk. Critically, these systems inform conversations rather than determine access. The prescriber evaluates every signal in clinical context and makes all treatment decisions. This work sits inside our broader healthcare AI practice, where validation, bias monitoring, and regulatory classification are engineering deliverables rather than late additions.
Risk Factor Surfacing
Opioid risk stratification support surfaces documented factors for clinician consideration. It never produces a score that limits prescribing, and the prescriber weighs every factor clinically.
Patient-Reported Outcome Tracking
Patient-reported outcomes capture pain interference, function, and mood over time, structuring the longitudinal data that treatment response conversations depend on.
Functional Progress Analysis
Analysis of mobility, activity, and therapy adherence data produces functional outcome trends, supporting the physician’s assessment of whether a treatment plan is working.
Procedure and Injection Documentation
Interventional pain documentation tooling captures block, injection, and implant details with structured fields, reducing dictation while preserving physician review of every note.
Decision Support Boundaries
Every output carries clinical decision support framing. The software does not deny prescriptions, mandate tapering, restrict access, or make treatment decisions in any configuration we build.
Core AI Pain Management Services
Our AI pain management services cover data integration, outcome capture, risk review tooling, behavioral health coordination, and reporting. Pain practices operate under prescribing regulation that varies by state, and integration with prescription monitoring programs is governed by legal access rules rather than technical capability alone. We scope those constraints explicitly. Engagements typically open with a review of EHR structure, e-prescribing configuration, current outcome collection practice, and applicable state requirements. Deliverables are structured so physicians, compliance officers, and IT can each review their portion before anything reaches live clinical use.
01
EHR and Prescribing Integration
Integration connects medication records, orders, and notes with your chart. Our EHR and EMR integration practice covers the interface layer and write-back handling.
02
E-Prescribing and PDMP Connectivity
PDMP integration is governed by state access rules. We build connectivity within those constraints, drawing on our Surescripts integration work for e-prescribing interfaces.
03
Outcome Instrument Automation
We implement validated instruments with automated scheduling and scoring, so PROMIS and similar measures are collected consistently rather than sporadically at visits.
04
Remote Monitoring Integration
Wearable and app-based data extends visibility between visits, building on our remote patient monitoring software development work for activity tracking integration.
05
Behavioral Health Coordination
Pain and mental health are intertwined. Coordination tooling supports referral and shared care, complementing behavioral health software development with 42 CFR Part 2 consent handling.
06
Model Monitoring and Bias Review
We instrument drift detection and mandatory bias monitoring across race, sex, and age, because documented disparities in pain treatment make unmonitored risk models genuinely dangerous.
Benefits of AI Pain Management Software
The benefits of AI pain management software concentrate in longitudinal visibility, documentation quality, and consistency of outcome collection. Pain care depends on tracking change over months, yet most practices capture outcomes inconsistently and reconstruct history manually. Structured data also strengthens the clinical record supporting each prescribing decision, which matters under regulatory review. We publish no figures on opioid reduction, pain scores, or function, because those depend entirely on patient population and clinical practice. What we deliver is instrumentation so your practice measures against its own data.
Longitudinal Visibility
Consolidated timelines make treatment response visible across months rather than requiring reconstruction from scattered notes at every visit.
Consistent Outcome Collection
Automated instrument scheduling produces comparable pain interference and function data over time, replacing collection that otherwise depends on visit-day workload.
Stronger Clinical Documentation
Structured capture of assessment, rationale, and monitoring produces a defensible record for each prescribing decision, which matters under payer and regulatory review.
Better Care Coordination
Shared visibility across pain, primary care, physical therapy, and behavioral health supports chronic care management workflows and reduces care fragmentation.
Reduced Administrative Load
Automated documentation and prior authorization data preparation lower administrative work, easing clinic throughput pressure without shortening patient contact time.
More Informed Risk Conversations
Organized context supports honest risk discussion between clinician and patient, which is the appropriate use of these signals rather than access restriction.
Our AI Pain Management Process
We deliver AI pain management projects in gated phases so clinical and compliance stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, data availability, applicable state prescribing rules, and regulatory classification. Development is iterative with physician review inside each cycle. Deployment is staged, and for any risk-related feature we require a documented bias evaluation before clinical exposure, not after. This is stricter than our default process because pain management risk models carry a well-documented history of encoding disparities into clinical decisions, and that failure mode is unacceptable.
Discovery and Regulatory Assessment
Discovery defines intended use, evaluates data access, reviews state prescribing rules, and assesses whether SaMD classification applies, producing a fixed-scope estimate.
Data and Instrument Planning
We map EHR fields, select validated outcome instruments with your clinicians, and plan collection cadence, since inconsistent capture undermines every downstream analysis.
Model Development and Validation
Development runs to held-out validation with performance reported by race, sex, age, and diagnosis, so disparate behavior is documented and addressed before deployment.
Mandatory Bias Evaluation
Any risk-related model passes a documented fairness evaluation with your clinical governance group. Features failing that review are revised or dropped rather than shipped with caveats.
Workflow Integration and Review
Integration places signals where the prescriber already works, preserving clinical autonomy and ensuring no interface element reads as an authorization or denial.
Staged Rollout and Governance
Rollout expands with performance dashboards, clinical governance review, and continuing post-deployment surveillance for the life of the deployment.
Technology and Compliance
Pain management software handles PHI, controlled substance prescribing data, and in many configurations substance use disorder records subject to 42 CFR Part 2, which imposes consent requirements well beyond HIPAA. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. PDMP connectivity is constrained by state law governing who may query and for what purpose, so it is a legal question before it is a technical one. Where software produces risk output intended to guide prescribing, SaMD classification may apply. We assess all of this during discovery.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
42 CFR Part 2 Handling
42 CFR Part 2 requires segmented storage, granular consent, and redisclosure controls for substance use records. We implement this structurally rather than through access policy alone.
PDMP Access Constraints
PDMP integration depends on state statute defining permitted queriers and purposes. We build to your state’s rules and document the access basis for every query.
SaMD and FDA Considerations
Risk output guiding prescribing may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Fairness and Bias Controls
Bias monitoring is mandatory rather than optional here, with subgroup performance reported continuously, because pain treatment disparities are extensively documented in the literature.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before production release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. In pain management specifically we have shipped FDA-registered applications, Revive Ease and PainKare, which means we have worked inside this domain’s regulatory and clinical constraints rather than approaching it as a new vertical. Our leadership brings more than 20 years of personal experience in the field, which shapes how we scope work in regulated, high-scrutiny clinical areas.
01
Direct Pain Domain Experience
Revive Ease and PainKare are FDA-registered pain applications we built, giving us practical familiarity with pain workflows, outcome instruments, and regulatory expectations.
02
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow and prescribing systems.
03
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means EHR integration is handled by engineers who have built systems on both sides of the interface, not only consumed an API.
04
Sensitive Data Handling
Delivering CHIPSS for behavioral health required consent segmentation under strict rules, experience that transfers directly to 42 CFR Part 2 obligations in pain care.
05
Decision Support Engineering
We build clinical decision support with prescriber autonomy protected by design, an approach detailed in our clinical decision support software development practice.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment without a long remediation phase.
Pricing
AI pain management pricing depends on scope, integration surface, regulatory constraints, and whether risk-related modeling is in scope. An outcome collection module costs considerably less than a platform integrating PDMP connectivity, behavioral health consent segmentation, and validated risk review. We price after discovery, because state prescribing rules and EHR configuration vary widely and drive a large share of total effort. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown so components can be approved or deferred. Cloud infrastructure, e-prescribing network fees, and instrument licensing are separate from engineering cost and itemized clearly.
MVP or Single Module
An MVP covering one capability such as automated outcome collection typically runs $40,000 to $80,000, validating clinical value before broader commitment.
Full Platform Build
A full platform with EHR integration, PDMP connectivity, outcome tracking, coordination tooling, and analytics typically falls between $80,000 and $200,000 depending on validation depth.
Enterprise Deployment
Enterprise engagements covering multi-site rollout, custom model development, fairness validation, and regulatory documentation start at $200,000 and scale with site count.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and regulatory assessment. It is deliberately separable so you can evaluate our work first.
Cost Drivers to Expect
PDMP access complexity, 42 CFR Part 2 segmentation, multi-state rule variation, and fairness validation are the largest variables, each identified during discovery for realistic budget planning.
Ongoing Support Costs
Post-launch bias monitoring, revalidation, regulatory rule updates, and support are quoted separately as a retainer sized to your footprint and governance cadence.
Get Started
If you are evaluating AI pain management tooling for outcome tracking, prescribing history review, coordination, or documentation, the fastest next step is a discovery call with our clinical engineering team. We will review your EHR configuration, applicable state rules, and intended use, then return an itemized, fixed-scope estimate with a clear regulatory and fairness assessment. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Practices evaluating AI pain management software raise concerns that differ from other specialties: whether software will restrict patient access to treatment, how substance use records are protected, and whether risk models encode bias. Those concerns are well founded, and the answers below reflect how we actually handle them. If your situation spans multiple states, involves 42 CFR Part 2 data, or contemplates risk output guiding prescribing, the specifics matter more than any general answer.
No. We do not build software that denies prescriptions, mandates tapering, or restricts access. Risk-related features surface documented factors for the prescriber to weigh in clinical context, and the interface is designed so no element reads as an authorization or refusal. Every treatment decision remains entirely with the treating clinician.
Bias evaluation is a required gate rather than a monitoring afterthought. We report performance by race, sex, age, and diagnosis before deployment, review results with your clinical governance group, and revise or drop features that show disparate behavior. Monitoring continues after launch, because pain treatment disparities are extensively documented.
Sometimes, and it depends on statute rather than technology. State law defines who may query the PDMP, for what purpose, and through which channels, and some states restrict integration entirely. We assess your specific state rules during discovery and document the legal access basis for every query the software makes.
An MVP or single module runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with multi-site rollout and regulatory documentation start at $200,000. Discovery produces an itemized, fixed-scope estimate, with infrastructure and network fees quoted separately from engineering.
Records subject to 42 CFR Part 2 are stored in segmented form with granular consent tracking and redisclosure controls, implemented in the data model rather than enforced only by access policy. Consent status is surfaced to users before any disclosure, and audit history covers every access and release event.
It depends on intended use. Risk output intended to guide prescribing decisions may meet the definition of Software as a Medical Device and require a regulatory pathway, while outcome collection and documentation tooling generally does not. We assess classification during discovery and build the design controls your pathway requires.